Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2020-03-31 Report Publication Anno…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2020
Report Publication Announcement Classification · 98% confidence The document title is "Blue Vision A/S årsregnskab 2019" (Annual Report 2019). The text explicitly states that the Board of Directors has processed and approved the company's 'årsrapport' (annual report). It contains detailed financial performance summaries for the year (result, equity) and outlook for the next year. Although it contains the content of an annual report, the document is very short (2265 chars) and concludes with an attachment link: "Vedhæftet fil - [Blue Vision Årsrapport 2019 - (final31032020)]". According to Rule #2 (The 'MENU VS MEAL' Rule), when a short document announces or attaches the full report, it should be classified as a Report Publication Announcement (RPA). If it were the full report, it would typically be classified as 10-K, but the structure strongly suggests this is the press release announcing the availability of the full annual report.
2020-03-31 Danish
Audit Report / Information 2019
Audit Report / Information Classification · 98% confidence The document contains a detailed 'Indhold' (Table of Contents) listing sections like 'Ledelsespåtegning' (Management's Report), 'Den uafhængige revisors revisionspåtegning' (The independent auditor's report), 'Ledelsesberetning' (Management commentary), 'Årsregnskab' (Annual accounts), 'Resultatopgørelse' (Income statement), 'Balance' (Balance sheet), and 'Pengestrømsopgørelse' (Cash flow statement). The text explicitly refers to the 'årsrapporten for 2019' (annual report for 2019) and the reporting period is '1. januar – 31. december 2019'. The presence of a full set of audited financial statements and the management/auditor reports strongly indicates this is the comprehensive annual report. Although it contains an Audit Report section, the overall document structure and scope align best with the Annual Report (10-K equivalent for non-US filers, or the comprehensive annual filing). Given the options, '10-K' is the closest equivalent for a full annual report, although 'AR' (Audit Report/Information) is also present, the document is clearly more than just the audit report itself. FY 2019
2020-03-31 English
Legal Proceedings Report 2020
Legal Proceedings Report Classification · 99% confidence The document is a formal announcement from Blue Vision A/S dated February 21, 2020, regarding a decision by the Danish Business Authority (Erhvervsstyrelsen) to administratively reverse a capital reduction. The text discusses legal/regulatory actions concerning capital structure and creditor claims, specifically mentioning the Danish Companies Act (§ 193, stk. 4) and the intent to appeal the decision to the Trade Appeals Board (Erhvervsankenævnet). This content relates directly to changes in capital structure and legal/regulatory compliance regarding financing activities. While it touches upon capital structure (CAP), the core subject is a regulatory/legal dispute over the validity of a capital reduction. Since it is a specific announcement about a regulatory decision impacting capital, it fits best under Capital/Financing Update (CAP) or potentially Legal Proceedings Report (LTR). Given the focus on the administrative reversal of a 'kapitalnedsættelse' (capital reduction) and the immediate steps to secure financing (issuing a bank guarantee), CAP is the most appropriate primary classification, as it directly concerns the company's capital structure management and financing compliance.
2020-02-21 Danish
M&A Activity 2019
M&A Activity Classification · 99% confidence The document is a company announcement (Selskabsmeddelelse) dated December 18, 2019, detailing the potential acquisition (køb) of 100% of the share capital in two companies. It specifies the expected transaction price (17.5M DKK), expected revenue, and due diligence conditions. This content directly relates to a significant corporate transaction involving mergers or acquisitions. Therefore, the appropriate classification is 'M&A Activity' (TAR). The document is not a full report, an earnings release, or a general regulatory filing, but a specific announcement about a takeover/merger proposal.
2019-12-18 Danish
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 98% confidence The document is titled "Blue Vision A/S – Storaktionærmeddelelse" (Major Shareholder Announcement) and explicitly states that Nicolai Kærgaard increased his holding in the company, crossing a threshold (11.75%). This directly relates to changes in significant share ownership. According to the definitions, this aligns perfectly with the Major Shareholding Notification (MRQ). The document is short and appears to be the official notification itself, not an announcement about a forthcoming report.
2019-11-07 Danish
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 98% confidence The document is titled "Blue Vision A/S – Storaktionærmeddelelse" (Major Shareholder Announcement) and explicitly states that Peter Hauge Jensen has increased his holding in Blue Vision A/S to 12.17% of the total share capital, referencing § 30 of the Danish Capital Markets Act. This content directly relates to reporting changes in significant share ownership thresholds by an individual or entity. This matches the definition for Major Shareholding Notification (MRQ). The document is short and reports a specific transaction/holding change, not an announcement of a larger report.
2019-11-07 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.